SofWave Medical Ltd. (TLV:SOFW)

Market Cap	1.28B +127.6%
Revenue (ttm)	255.13M +36.1%
Net Income	2.26M
EPS	0.06
Shares Out	36.10M
PE Ratio	565.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,188
Average Volume	47,600
Open	3,555.00
Previous Close	3,555.00
Day's Range	3,550.00 - 3,595.00
52-Week Range	1,300.00 - 3,800.00
Beta	0.87
RSI	58.76
Earnings Date	Mar 5, 2026

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. The company was incorporated in 2015 a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2015
• Employees: 126
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: SOFW

Financial Performance

In 2024, SofWave Medical's revenue was $59.65 million, an increase of 18.56% compared to the previous year's $50.32 million. Losses were -$4.55 million, -45.08% less than in 2023.

Financial numbers in USD